Rapport Therapeutics, Inc.
RAPP
$11.49
$0.110.97%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 305.28M | 320.66M | 336.14M | 193.24M | 147.48M |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 300.00K | 900.00K | 1.30M | 5.38M | 1.50M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 4.22M | 4.38M | 3.23M | 105.00K | 1.89M |
| Total Current Assets | 309.80M | 325.94M | 340.67M | 198.73M | 150.87M |
|
|
|||||
| Total Current Assets | 309.80M | 325.94M | 340.67M | 198.73M | 150.87M |
| Net Property, Plant & Equipment | 4.97M | 5.02M | 5.24M | 5.49M | 4.00M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 160.00K | 189.00K | 189.00K | 2.07M | 551.00K |
| Total Assets | 314.93M | 331.14M | 346.10M | 206.29M | 155.42M |
|
|
|||||
| Total Accounts Payable | 1.95M | 1.32M | 1.88M | 1.45M | 2.50M |
| Total Accrued Expenses | 6.08M | 5.06M | 5.52M | 7.75M | 5.63M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 737.00K | 720.00K | 703.00K | 686.00K | 670.00K |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 8.77M | 7.10M | 8.10M | 9.89M | 8.80M |
|
|
|||||
| Total Current Liabilities | 8.77M | 7.10M | 8.10M | 9.89M | 8.80M |
| Long-Term Debt | -- | -- | -- | -- | 4.20M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 739.00K | 931.00K | 1.12M | 1.30M | 1.48M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 9.51M | 8.03M | 9.21M | 11.18M | 14.48M |
|
|
|||||
| Common Stock & APIC | 429.69M | 426.48M | 423.30M | 28.63M | 19.80M |
| Retained Earnings | -123.75M | -103.77M | -86.23M | -68.11M | -45.44M |
| Treasury Stock & Other | -522.00K | 400.00K | -183.00K | -160.00K | 4.00K |
| Total Common Equity | 305.43M | 323.11M | 336.89M | -39.63M | -25.63M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | 234.74M | 166.58M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | 234.74M | 166.58M |
|
|
|||||
| Total Common Equity | 305.43M | 323.11M | 336.89M | -39.63M | -25.63M |
| Total Preferred Equity | -- | -- | -- | 234.74M | 166.58M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 305.43M | 323.11M | 336.89M | 195.11M | 140.94M |
|
|
|||||